Diabetescare.abbott

ABBOTT PARK, Ill., July 22, 2015 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2015. “We’ve achieved another quarter of strong sales growth led by our global diagnostics and branded generics...

By Lynn Kennedy, Ava Runge, and Adam Brown What Abbott, Dexcom, LifeScan, Medtronic, Tandem, and others are bringing to make diabetes easier and less burdensome We’re living in the most exciting time ever in diabetes technology, and a slew of soon...

Abbott (NYSE:ABT) said today it won CE Mark approval in the European Union for its FreeStyle Libre flash glucose monitoring system for patients aged 4-17. The FreeStyle Libre flash is designed to monitor glucose through a sensor worn on the back of...

Melia Robinson/Business Insider Chrissy Ensley, head of operations and supply chain at Nootrobox, shows off her continuous glucose monitor. Paul Benigeri, a lead engineer at cognitive enhancement supplement startup Nootrobox, flexes his tricep nervously...

[Capital Cube] Abbott Laboratories (NYSE:ABT)(TREND ANALYSIS) reported preliminary financial results for the quarter ended March 31, 2015 with an adjusted EPS of 47 cents versus a consensus estimate of 42 cents. The earnings beat was helped by the sale...